Skip to content
DataLookout
Menu

LAPIX Therapeutics Inc. clinical trial pipeline

Get alerts when LAPIX Therapeutics Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis Primary completion pushed from Dec 15, 2025 to Nov 15, 2026 LAPIX Therapeutics Inc.Phase 1 NCT06628206
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1
2

Disease areas by active trials

Get alerts when LAPIX Therapeutics Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free